Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6

Detalhes bibliográficos
Autor(a) principal: Pereira, Venúcia Bruna Magalhães
Data de Publicação: 2013
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da Universidade Federal do Ceará (UFC)
dARK ID: ark:/83112/0013000027sqt
Texto Completo: http://www.repositorio.ufc.br/handle/riufc/8161
Resumo: Introduction: Intestinal mucositis is a common side effect of anticancer regimens for first-line treatment of colorectal cancer. Among such drugs are irinotecan and 5-FU used in combination. Many studies have been conducted on the pathogenesis of MI. However, further investigations are necessary, because the course of MI may vary according to the drug regimen and employees. Then aimed to develop a new experimental model of MI induced by the combination of IRI and 5-FU in mice. Methods and Results: C57BL/6 mice (20-25g, n=6) were injected with saline (100µL, i.p), IRI (30 or 45 mg/kg, i.p), 5-FU (25, 37.5 or 50 mg/kg, i.p) or IRI+5-FU for 4 days. On day 7, diarrhea, weight loss, and blood leukocyte count were registered. Following animal euthanasia, ileum samples were collected for histopathological analysis, myeloperoxidase activity (MPO, neutrophil/mg protein), TNF-α and IL-6 levels (pg/mg tissue). Kaplan-Mayer log rank test, Kruskal Wallis/Dunn’s or ANOVA/Bonferroni’s test was used for statistical analysis. p<0.05 was accepted. The best dose combination able to induce IM with no important mortality on day 7 was 5-FU (37.5 mg/kg) +IRI (45 mg/kg) (0% mortality), which was then used for subsequent studies. IRI+5-FU induced (p<0.001) diarrhea (2[0-3]), weight loss (86.7±3.9g), and leukopenia (7.3± 2.3 x103) versus saline group (0[0-1]; 101.1±0.6; 215.5± 54.1, respectively) or each drug given alone (5-FU: diarrhea (0[0-1]), weight loss [92.6±2.7], and leukopenia [30.4± 13.4]; IRI: diarrhea (0[0-1]), weight loss [94.8±2.1], and leukopenia [49.2± 5.5]). In addition, IRI+5-FU induced inflammatory cells infiltration, and loss of villi and crypt architecture (4[3-4]), increased in MPO activity (14641±1598 neutrophil/mgproteín), TNF-a (3.2±0.9 pg/mg tissue), IL-6 (1.4±0.5 pg/mg tissue) tissue levels versus saline-injected group (0[0-1], 5747±1155; 0.7±0.2; 0.3±0.1) or the drugs injected alone (5-FU: Intestinal damage (2.5[2-3]), MPO [3788±1212], TNF-α [0.7±0.2], IL-6 [0.2±2.3]; IRI: Intestinal damage (1[0-2]), MPO [3580±1613], TNF-α [0.4±0,2], IL-6 [0.07±0.05]) (p<0.05). Conclusion: We developed a new experimental model of IM induced by the combination of IRI+5-FU in mice, which opens perspective for a more appropriate knowledge concerning the pathogenesis of IM.
id UFC-7_8eb4560b65ba88f961e3f75aeeec155c
oai_identifier_str oai:repositorio.ufc.br:riufc/8161
network_acronym_str UFC-7
network_name_str Repositório Institucional da Universidade Federal do Ceará (UFC)
repository_id_str
spelling Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6InflamaçãoMucositeIntroduction: Intestinal mucositis is a common side effect of anticancer regimens for first-line treatment of colorectal cancer. Among such drugs are irinotecan and 5-FU used in combination. Many studies have been conducted on the pathogenesis of MI. However, further investigations are necessary, because the course of MI may vary according to the drug regimen and employees. Then aimed to develop a new experimental model of MI induced by the combination of IRI and 5-FU in mice. Methods and Results: C57BL/6 mice (20-25g, n=6) were injected with saline (100µL, i.p), IRI (30 or 45 mg/kg, i.p), 5-FU (25, 37.5 or 50 mg/kg, i.p) or IRI+5-FU for 4 days. On day 7, diarrhea, weight loss, and blood leukocyte count were registered. Following animal euthanasia, ileum samples were collected for histopathological analysis, myeloperoxidase activity (MPO, neutrophil/mg protein), TNF-α and IL-6 levels (pg/mg tissue). Kaplan-Mayer log rank test, Kruskal Wallis/Dunn’s or ANOVA/Bonferroni’s test was used for statistical analysis. p<0.05 was accepted. The best dose combination able to induce IM with no important mortality on day 7 was 5-FU (37.5 mg/kg) +IRI (45 mg/kg) (0% mortality), which was then used for subsequent studies. IRI+5-FU induced (p<0.001) diarrhea (2[0-3]), weight loss (86.7±3.9g), and leukopenia (7.3± 2.3 x103) versus saline group (0[0-1]; 101.1±0.6; 215.5± 54.1, respectively) or each drug given alone (5-FU: diarrhea (0[0-1]), weight loss [92.6±2.7], and leukopenia [30.4± 13.4]; IRI: diarrhea (0[0-1]), weight loss [94.8±2.1], and leukopenia [49.2± 5.5]). In addition, IRI+5-FU induced inflammatory cells infiltration, and loss of villi and crypt architecture (4[3-4]), increased in MPO activity (14641±1598 neutrophil/mgproteín), TNF-a (3.2±0.9 pg/mg tissue), IL-6 (1.4±0.5 pg/mg tissue) tissue levels versus saline-injected group (0[0-1], 5747±1155; 0.7±0.2; 0.3±0.1) or the drugs injected alone (5-FU: Intestinal damage (2.5[2-3]), MPO [3788±1212], TNF-α [0.7±0.2], IL-6 [0.2±2.3]; IRI: Intestinal damage (1[0-2]), MPO [3580±1613], TNF-α [0.4±0,2], IL-6 [0.07±0.05]) (p<0.05). Conclusion: We developed a new experimental model of IM induced by the combination of IRI+5-FU in mice, which opens perspective for a more appropriate knowledge concerning the pathogenesis of IM.Introdução: Mucosite intestinal é um efeito adverso comum dos regimes anticâncer de primeira linha para o tratamento do câncer colorretal. Dentre esses fármacos estão o irinotecano e 5-FU utilizados em associação. Muitos estudos têm sido realizados sobre a patogênese da MI. No entanto, novas investigações são necessarias, pois o curso da MI pode variar de acordo com o fármaco e regime empregados. Objetivou-se então desenvolver um novo modelo experimental de MI induzida pela combinação de IRI e 5-FU em camundogos. Métodos e Resultados: camundongos C57BL/6 (20-25g, n=6) foram injetados com salina (100µL, i.p), IRI (30 ou 45 mg/kg, i.p), 5-FU (25, 37,5 ou 50 mg/kg, i.p) ou IRI+5-FU em doses combinadas por 4 dias. No 7º dia, diarreia, perda de peso e contagem de leucócitos foram registradas. Após a eutanásia dos animais, amostras do íleo foram coletadas para análise histopatológica, atividade de mieloperoxidase (neutrófilo/mg proteína), níveis de TNF-α e IL-6 (pg/mg tecido). Teste Kaplan-Mayer log rank, Kruskal Wallis/Dunn’s ou teste ANOVA/Bonferroni foram usados para analise estatistica. p<0,05 foi aceito como significativo. A melhor combinação de dose para induzir a MI sem mortalidade importante no 7º dia foi 5-FU (37,5 mg/kg) + IRI (45 mg/kg) (0% mortalidade), que foi então usada para estudos subsequentes. IRI+5-FU induziu (p<0,001) diarreia (2[0-3]), perda de peso (86,7±3,9g), e leucopenia (7,3± 2,3x103) versus grupo salina (0[0-1]; 101,1±0,6; 215,5± 54,1, respectivamente) ou cada droga dada sozinha (5-FU: diarreia (0[0-1]), perda de peso [92,6±2,7], e leucopenia [30,4± 13,4]; IRI: diarreia (0[0-1]), perda de peso [94,8±2,1], e leucopenia [49,2± 5,5]). Adicionalmente, IRI+5-FU induziu infiltrado de células inflamatórias, perda de vilos e arquitetura das criptas (4[4-4]), aumento na atividade de MPO (14641±1598 neutrófilo/mgproteína), TNF-a (3,2±0,9 pg/mg de tecido), IL-6 (1,4±0,5 pg/mg de tecido) níveis teciduais versus grupo injetado com salina (0[0-1], 5747±1155; 0,7±0,2; 0,3±0,1) ou com fármacos injetados isoladamente (5-FU: dano intestinal (2.5[2-3]), MPO [3788±1212], TNF-α [0,7±0,2], IL-6 [0,2±2,3]; IRI: dano intestinal (1[0-2]), MPO [3580±1613], TNF-α [0,4±0,2], IL-6 [0,07±0,05]) (p<0,05). Conclusão: Desenvolvemos um novo modelo experimental de MI induzida pela combinação de IRI+5-FU em camundongos, que abre perspectiva para um maior conhecimento sobre a patogênese da MI.Lima Júnior , Roberto César PereiraPereira, Venúcia Bruna Magalhães2014-06-03T12:06:52Z2014-06-03T12:06:52Z2013info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfPEREIRA, Venúcia Bruna Magalhães. Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6. 2013. 104 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal do Ceará. Faculdade de Medicina, Fortaleza, 2013. Disponível em: http://www.repositorio.ufc.br/handle/riufc/8161. Acesso em: 24 jul. 2023.http://www.repositorio.ufc.br/handle/riufc/8161ark:/83112/0013000027sqtporreponame:Repositório Institucional da Universidade Federal do Ceará (UFC)instname:Universidade Federal do Ceará (UFC)instacron:UFCinfo:eu-repo/semantics/openAccess2023-07-24T11:31:44Zoai:repositorio.ufc.br:riufc/8161Repositório InstitucionalPUBhttp://www.repositorio.ufc.br/ri-oai/requestbu@ufc.br || repositorio@ufc.bropendoar:2024-09-11T19:02:29.332886Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)false
dc.title.none.fl_str_mv Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6
title Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6
spellingShingle Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6
Pereira, Venúcia Bruna Magalhães
Inflamação
Mucosite
title_short Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6
title_full Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6
title_fullStr Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6
title_full_unstemmed Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6
title_sort Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6
author Pereira, Venúcia Bruna Magalhães
author_facet Pereira, Venúcia Bruna Magalhães
author_role author
dc.contributor.none.fl_str_mv Lima Júnior , Roberto César Pereira
dc.contributor.author.fl_str_mv Pereira, Venúcia Bruna Magalhães
dc.subject.por.fl_str_mv Inflamação
Mucosite
topic Inflamação
Mucosite
description Introduction: Intestinal mucositis is a common side effect of anticancer regimens for first-line treatment of colorectal cancer. Among such drugs are irinotecan and 5-FU used in combination. Many studies have been conducted on the pathogenesis of MI. However, further investigations are necessary, because the course of MI may vary according to the drug regimen and employees. Then aimed to develop a new experimental model of MI induced by the combination of IRI and 5-FU in mice. Methods and Results: C57BL/6 mice (20-25g, n=6) were injected with saline (100µL, i.p), IRI (30 or 45 mg/kg, i.p), 5-FU (25, 37.5 or 50 mg/kg, i.p) or IRI+5-FU for 4 days. On day 7, diarrhea, weight loss, and blood leukocyte count were registered. Following animal euthanasia, ileum samples were collected for histopathological analysis, myeloperoxidase activity (MPO, neutrophil/mg protein), TNF-α and IL-6 levels (pg/mg tissue). Kaplan-Mayer log rank test, Kruskal Wallis/Dunn’s or ANOVA/Bonferroni’s test was used for statistical analysis. p<0.05 was accepted. The best dose combination able to induce IM with no important mortality on day 7 was 5-FU (37.5 mg/kg) +IRI (45 mg/kg) (0% mortality), which was then used for subsequent studies. IRI+5-FU induced (p<0.001) diarrhea (2[0-3]), weight loss (86.7±3.9g), and leukopenia (7.3± 2.3 x103) versus saline group (0[0-1]; 101.1±0.6; 215.5± 54.1, respectively) or each drug given alone (5-FU: diarrhea (0[0-1]), weight loss [92.6±2.7], and leukopenia [30.4± 13.4]; IRI: diarrhea (0[0-1]), weight loss [94.8±2.1], and leukopenia [49.2± 5.5]). In addition, IRI+5-FU induced inflammatory cells infiltration, and loss of villi and crypt architecture (4[3-4]), increased in MPO activity (14641±1598 neutrophil/mgproteín), TNF-a (3.2±0.9 pg/mg tissue), IL-6 (1.4±0.5 pg/mg tissue) tissue levels versus saline-injected group (0[0-1], 5747±1155; 0.7±0.2; 0.3±0.1) or the drugs injected alone (5-FU: Intestinal damage (2.5[2-3]), MPO [3788±1212], TNF-α [0.7±0.2], IL-6 [0.2±2.3]; IRI: Intestinal damage (1[0-2]), MPO [3580±1613], TNF-α [0.4±0,2], IL-6 [0.07±0.05]) (p<0.05). Conclusion: We developed a new experimental model of IM induced by the combination of IRI+5-FU in mice, which opens perspective for a more appropriate knowledge concerning the pathogenesis of IM.
publishDate 2013
dc.date.none.fl_str_mv 2013
2014-06-03T12:06:52Z
2014-06-03T12:06:52Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv PEREIRA, Venúcia Bruna Magalhães. Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6. 2013. 104 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal do Ceará. Faculdade de Medicina, Fortaleza, 2013. Disponível em: http://www.repositorio.ufc.br/handle/riufc/8161. Acesso em: 24 jul. 2023.
http://www.repositorio.ufc.br/handle/riufc/8161
dc.identifier.dark.fl_str_mv ark:/83112/0013000027sqt
identifier_str_mv PEREIRA, Venúcia Bruna Magalhães. Novo modelo de mucosite intestinal induzida pela associação de irinotecano e 5-fluorouracil em camundongos C57BL/6. 2013. 104 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal do Ceará. Faculdade de Medicina, Fortaleza, 2013. Disponível em: http://www.repositorio.ufc.br/handle/riufc/8161. Acesso em: 24 jul. 2023.
ark:/83112/0013000027sqt
url http://www.repositorio.ufc.br/handle/riufc/8161
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal do Ceará (UFC)
instname:Universidade Federal do Ceará (UFC)
instacron:UFC
instname_str Universidade Federal do Ceará (UFC)
instacron_str UFC
institution UFC
reponame_str Repositório Institucional da Universidade Federal do Ceará (UFC)
collection Repositório Institucional da Universidade Federal do Ceará (UFC)
repository.name.fl_str_mv Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)
repository.mail.fl_str_mv bu@ufc.br || repositorio@ufc.br
_version_ 1818374085320638464